Implications of protein flexibility for drug discovery

被引:0
|
作者
Simon J. Teague
机构
[1] AstraZeneca R&D Charnwood,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A large number of pharmaceutically relevant targets have been shown to be flexible, which are collected in this article. This comprehensive list of present and historical pharmaceutical targets provides the basis for questioning the relevance of the rigid receptor hypothesis, which is commonly used during in silico drug design.The role of protein flexibility in future pharmaceutical targets is likely to be even greater than in the past. Presently under-exploited target classes, such as ion channels, nuclear hormone receptors and transporters, have functions that are inextricably bound up with their structural flexibility.This article uses illustrative examples to discuss the implications of protein flexibility in drug discovery, and highlights how it could be exploited in drug design.
引用
收藏
页码:527 / 541
页数:14
相关论文
共 50 条
  • [21] Protein-protein interactions in drug discovery
    Sankar, U
    GENETIC ENGINEERING NEWS, 2005, 25 (05): : 30 - +
  • [22] A Molecular Dynamics Investigation of Mycobacterium tuberculosis Prenyl Synthases: Conformational Flexibility and Implications for Computer-aided Drug Discovery
    Kim, Meekyum Olivia
    Feng, Xinxin
    Feixas, Ferran
    Zhu, Wei
    Lindert, Steffen
    Bogue, Shannon
    Sinko, William
    de Oliveira, Cesar
    Rao, Guodong
    Oldfield, Eric
    McCammon, James Andrew
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 756 - 769
  • [23] Exploiting Protein Intrinsic Flexibility in Drug Design
    Lukman, Suryani
    Verma, Chandra S.
    Fuentes, Gloria
    PROTEIN CONFORMATIONAL DYNAMICS, 2014, 805 : 245 - 269
  • [24] Understanding the challenges of protein flexibility in drug design
    Antunes, Dinler A.
    Devaurs, Didier
    Kavraki, Lydia E.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (12) : 1301 - 1313
  • [25] Accommodating protein flexibility in computational drug design
    Carlson, HA
    McCammon, JA
    MOLECULAR PHARMACOLOGY, 2000, 57 (02) : 213 - 218
  • [26] Targeting protein ubiquitination for drug discovery. What is in the drug discovery toolbox?
    Swinney, DC
    DRUG DISCOVERY TODAY, 2001, 6 (05) : 244 - 250
  • [27] COMP 17-Protein loop flexibility around ligand binding sites: Implications for drug design
    Weigelt, Carolyn A.
    Rossi, Karen A.
    Nayeem, Akbar
    Krystek, Stanley R., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [28] Developing models for cachexia and their implications in drug discovery
    Konishi, Masaaki
    Ebner, Nicole
    von Haehling, Stephan
    Anker, Stefan D.
    Springer, Jochen
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (07) : 743 - 752
  • [30] Synergy in natural medicines: Implications for drug discovery
    Li, Xue-Juan
    Zhang, Hong-Yu
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (07) : 331 - 332